Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-related share withholding, where 253 shares of common stock were withheld at $6.61 per share to satisfy obligations from vesting restricted stock units.
After this disposition, she holds 313,946 shares directly. Her position includes 223,001 shares tied to unvested RSUs and vested performance RSUs consisting of 2,489 PRSUs scheduled for release in March 2027 and 35,278 PRSUs, half to be released in April 2027 and the remainder in April 2028. The holdings also include 2,045 shares acquired under the 2021 Employee Stock Purchase Plan on May 8, 2026.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a routine tax-related share disposition. On May 8, 2026, 936 shares of Enovix common stock were withheld at $6.61 per share to cover tax withholding obligations tied to the vesting of restricted stock units (RSUs), rather than being sold in the open market.
After this withholding, Chakravarthy beneficially owns 603,555 shares, including 395,392 shares issuable upon future RSU vesting, 10,393 vested performance restricted stock units (PRSUs) scheduled for release in March 2027, and an additional 58,500 PRSUs expected to be released in April 2027 and April 2028.
Enovix Corp President and CEO Rajendra K. Talluri reported a routine tax-related share disposition. On May 8, 2026, 4,300 shares of common stock were withheld at $6.61 per share to satisfy tax obligations from the vesting of restricted stock units. After this withholding, he directly holds 3,075,845 shares, including 2,031,277 shares issuable upon RSU vesting and additional performance RSUs scheduled for release in 2027 and 2028.
Enovix Corporation has appointed industry veteran Steve Bakos as Senior Vice President of Worldwide Sales, a new role reporting to Chief Business Officer Samira Naraghi. The move supports commercial scale-up and revenue growth as Enovix prepares to launch its flagship 100% silicon-anode smartphone batteries and continues scaling its silicon-enhanced products from Korea.
Bakos brings more than 35 years of global semiconductor sales experience, including leading major accounts such as Apple at Infineon and prior VP roles at multiple analog and power semiconductor companies. Enovix also highlighted expanding commercial momentum across smartphones, smart eyewear, drones and defense applications.
The company announced it has reached alignment with its lead smartphone customer on a new silicon-specific qualification framework that better mirrors real-world conditions than legacy 0.7C testing. This updated testing extends duration and is producing results that are approaching required performance thresholds, which Enovix believes helps remove a key structural barrier to qualification and supports broader commercial opportunities.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a compensation-related share disposition tied to tax withholding. On this Form 4, 2,221 shares of Enovix common stock were withheld at $6.61 per share to satisfy tax obligations arising from the vesting of restricted stock units.
After this tax-withholding event, Chakravarthy holds 604,491 shares of Enovix common stock directly. This figure includes 397,158 shares issuable upon vesting and settlement of RSUs, 10,393 vested performance RSUs scheduled for release in March 2027, and 58,500 additional PRSUs to be released in April 2027 and April 2028.
Enovix Corporation filed its Annual Report on Form 10-K for the fiscal year ended December 28, 2025. The company describes its proprietary 3D silicon-anode cell architecture and the AI-1™ battery platform, reports manufacturing expansion in Malaysia and South Korea, and states Fab2 passed ISO 9001 and customer audits. The report discloses a volumetric energy density test of 935Wh/L for the AI-1 smartphone cell and highlights ongoing scale-up, supply-chain, and qualification risks.
Enovix Corporation is asking shareholders to vote at its virtual 2026 annual meeting on June 11, 2026, including electing eight directors, approving executive pay on an advisory basis, and ratifying Deloitte & Touche LLP as auditor.
In 2025 Enovix generated record revenue of $31.8 million, up 38% year over year, with non-GAAP gross margin improving to 23%. The company ended the year with about $621 million in cash and marketable securities and a global sales pipeline of roughly $100 million, largely in defense and drone applications.
Enovix executed approximately $60 million of share repurchases under a program expanded to $75 million, issued $360 million of convertible senior notes and a warrant dividend that produced $224 million of net proceeds, and continued scaling manufacturing in Malaysia and South Korea. The proxy highlights a pay-for-performance program in which about 92% of the CEO’s 2025 target compensation was at risk, with annual and long-term incentive payouts reduced where operational and financial goals were not fully achieved.
Enovix Corp President and CEO Rajendra K. Talluri reported a routine tax-related share disposition. On the transaction date, 17,651 shares of common stock were withheld at $6.62 per share to cover tax obligations tied to the vesting of restricted stock units.
After this withholding, he directly holds 3,080,145 shares of Enovix common stock. This total includes 2,039,397 shares issuable upon future RSU vesting and settlement, 47,775 vested performance RSUs scheduled for release in March 2027, and 259,611 additional performance RSUs scheduled for release in April 2027 and April 2028.
Enovix Corp Chief Financial Officer Ryan A. Benton reported an automatic share disposition tied to taxes, not an open-market sale. On the vesting of restricted stock units (RSUs), 79,725 shares of common stock were withheld at $6.36 per share to satisfy tax withholding obligations.
Following this tax-withholding disposition, Benton directly holds 922,968 shares of Enovix common stock. His position also includes 848,005 additional shares issuable upon future vesting and settlement of RSUs granted to him.
Enovix Corp Chief Accounting Officer Kristina Truong reported routine share withholdings to cover taxes tied to stock awards. On April 8, 10, and 13, 2026, a total of 2,945 shares of Enovix common stock were withheld at prices between $5.73 and $6.09 per share to satisfy tax withholding obligations on vesting restricted stock units.
These transactions, coded "F" as tax-withholding dispositions, were not open-market sales and did not generate trading proceeds for Truong. After the latest withholding, she directly holds 312,154 shares of Enovix common stock, including substantial shares underlying unvested RSUs and performance RSUs described in the footnotes.